Key facts
- This page summarizes Jay Pepose's Form 4 filing for Ocuphire Pharma, Inc. (IRD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Sep 2021, 08:00.
Jay Pepose - 13 Sep 2021 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)
- Reporting relationship
- Director
- Issuer ticker
- IRD
- Reported as of
- 13 Sep 2021
- Net transaction value
- +$59,997
- SEC form
- 4
- Accepted by SEC
- 15 Sep 2021, 08:00:31 UTC
- Prior SEC filing
- 09 Jun 2021
- Next SEC filing
- 14 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Emily J. Johns, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jay Pepose filed Form 4 for Ocuphire Pharma, Inc. (IRD) on 15 Sep 2021.
Change
- Previous filing in this sequence was filed on 09 Jun 2021.
- Current net transaction value: +$59,997.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCUP
transaction
Common Stock
Purchase
- Transaction value
- $59,997
- Shares
- +12,631
- Change %
- +598%
- Price
- $4.75
- Shares after
- 14,744
- Date
- 13 Sep 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.